Nay Maps is a South African actor born on 30th March 1989. He is the firstborn of three children born to the late Bishop Simeon Maphalala and his wife. Maps grew up alongside his two younger sisters ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD The US FDA has cleared two novel gene therapies ...

In December 2023, it was announced that the US Food and Drug Administration had approved two breakthrough treatments. 3 Lyfgenia and Casgevy are the first gene therapies available for treating sickle ...

If you’re trying to use Google Maps offline, we’re here to help. We’ve put together a simple set of instructions on how you can use Google’s app without an internet connection, just in case you’re ...

Google Maps is likely your go-to app for getting from point A to point B, but it's more than a navigation tool. Whether you're finding places, checking public transit schedules, or exploring new ...

The company's focus on innovative treatments, particularly its lead product Lyfgenia for sickle cell disease (SCD), has garnered attention from investors and analysts alike. However, recent financial ...

This new valuation considers the sum-of-the-parts probability-adjusted discount cash flows of key products like Skysona, Zynteglo, and Lyfgenia, each showing substantial value growth. The ...

Elsewhere, Bluebird recorded its first Lyfgenia revenue and Leerink built up its M&A team. Adaptimmune Therapeutics PLC (ADAP) outlines a path to operating breakeven by 2027, driven by strategic ...